In this deep-dive episode, Dr. Faisal Rafiq explores the clinical science, supervision nuances, and lived experience surrounding Spravato® (esketamine) and IV ketamine as tools for treatment-resistant depression (TRD), suicidality, and trauma-linked shutdown. Through the story of Emily, a 32-year-old nurse whose depression was unresponsive to conventional treatments, we see how structured ketamine therapy provided more than symptom relief—it offered a psychological reset.
Information
- Show
- FrequencyUpdated Monthly
- PublishedJune 3, 2025 at 10:59 PM UTC
- Length12 min
- Season1
- Episode6
- RatingClean
